Myelodysplastic Syndromes: Recent Progress in Diagnosis and Understanding of Their Pathophysiology-Reference-Cited by-同舟云学术

Myelodysplastic Syndromes: Recent Progress in Diagnosis and Understanding of Their Pathophysiology

Published:2006 Issue:6 Volume:73 Page:300-307
ISSN:1345-4676
Container-title:Journal of Nippon Medical School
language:en
Short-container-title:J Nippon Med Sch

Author:

Ogata Kiyoyuki¹

Affiliation:

1. Division of Hematology, Department of Medicine, Nippon Medical School

Publisher

Medical Association of Nippon Medical School

Subject

General Medicine

Link

http://www.jstage.jst.go.jp/article/jnms/73/6/73_6_300/_pdf

Reference69 articles.

1. The Myelodysplastic Syndromes: Diagnosis and Treatment

2. 2) Smith MT, Linet MS, Morgan GJ. Causative agents in the etiology of myelodysplastic syndromes and the acute myeloid leukemias. In The Myelodysplastic Syndromes: Pathobiology and Clinical Management (Bennett JM, ed), 2002; pp 29-63, Marcel Dekker, New York.

3. Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy [see comments]

4. 4) Hamblin TJ. Epidemiology of the myelodysplastic syndromes. In The Myelodysplastic Syndromes: Pathobiology and Clinical Management (Bennett JM, ed), 2002; pp 15-27, Marcel Dekker, New York.

5. Epidemiological Features of Myelodysplastic Syndromes: Results From Regional Cancer Surveys and Hospital-Based Statistics

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunophenotypic Profile of CD34+ Subpopulations and Their Role in the Diagnosis and Prognosis of Patients with De-Novo, Particularly Low-Grade Myelodysplastic Syndromes;Cytometry Part B: Clinical Cytometry;2018-10-17

2. Síndromes mielodisplásicos;Medicine - Programa de Formación Médica Continuada Acreditado;2012-11

3. Flow cytometry in myelodysplastic syndrome: analysis of diagnostic utility using maturation pattern-based and quantitative approaches;Annals of Hematology;2012-04-21

4. The clonogenic potential of selected CD34+ cells from patients with MDS appear preserved when tested ex vivo;Leukemia Research;2011-09

5. Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: A pilot study on a series of 56 patients;Cytometry Part B: Clinical Cytometry;2010